BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BridgeBio granted an aggregate of 66,810 restricted stock units to 30 new employees as an employment inducement material to their entry into the company. The awards were approved by the compensation committee on June 18, 2026, and were made pursuant to the Company’s 2019 equity incentive plan in accordance with Nasdaq Listing Rule 5635(c)(4).
Key figures
- New employees
- 30
- Aggregate shares
- 66810
- Initial vest percentage
- 25%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.